Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Rolstad Sindre 1976) "

Sökning: WFRF:(Rolstad Sindre 1976)

  • Resultat 21-30 av 46
  • Föregående 12[3]45Nästa
Sortera/gruppera träfflistan
  • Göthlin, Mattias, 1978, et al. (författare)
  • Prognostic Accuracy of Mild Cognitive Impairment Subtypes at Different Cut-Off Levels.
  • 2017
  • Ingår i: Dementia and geriatric cognitive disorders. - 1421-9824. ; 43:5-6, s. 330-341
  • Tidskriftsartikel (refereegranskat)abstract
    • The prognostic accuracy of mild cognitive impairment (MCI) in clinical settings is debated, variable across criteria, cut-offs, subtypes, and follow-up time. We aimed to estimate the prognostic accuracy of MCI and the MCI subtypes for dementia using three different cut-off levels.Memory clinic patients were followed for 2 (n = 317, age 63.7 ± 7.8) and 4-6 (n = 168, age 62.6 ± 7.4) years. We used 2.0, 1.5, and 1.0 standard deviations (SD) below the mean of normal controls (n = 120, age 64.1 ± 6.6) to categorize MCI and the MCI subtypes. Prognostic accuracy for dementia syndrome at follow-up was estimated.Amnestic multi-domain MCI (aMCI-md) significantly predicted dementia under all conditions, most markedly when speed/attention, language, or executive function was impaired alongside memory. For aMCI-md, sensitivity increased and specificity decreased when the cut-off was lowered from 2.0 to 1.5 and 1.0 SD. Non-subtyped MCI had a high sensitivity and a low specificity.Our results suggest that aMCI-md is the only viable subtype for predicting dementia for both follow-up times. Lowering the cut-off decreases the positive predictive value and increases the negative predictive value of aMCI-md. The results are important for understanding the clinical prognostic utility of MCI, and MCI as a non-progressive disorder.
  • Jonsson, Michael, 1955, et al. (författare)
  • Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia.
  • 2010
  • Ingår i: International journal of geriatric psychiatry. - 1099-1166. ; 25:6, s. 588-95
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE: Cerebral white-matter changes (WMCs) are frequently found in dementia and have been proposed to be related to vascular factors and a certain symptomatological profile. However, few studies have included both vascular factors and a broad spectrum of cognitive, neurological and psychiatric symptoms, easily detectable by the physician in the everyday clinical work. The objective was to study the relationships between WMCs on MRI/CT and neuropsychiatric symptoms and vascular factors in patients with cognitive impairment. METHODS: One hundred and seventy-six patients with Alzheimer's disease, vascular dementia, mixed dementia, and mild cognitive impairment were included. All patients underwent a standardized examination including medical history, clinical examinations, laboratory tests and brain imaging (CT or MRI). The identification and severity degree of WMCs was assessed blindly to clinical findings, using a semi-quantitative scale. For statistical analyses, patients were grouped based on absence or presence of WMCs. Significant variables in bivariate analyses were included as predictors in stepwise multiple logistic regression analyses. RESULTS: Bivariate analyses showed significant associations between WMCs and age, gender, blood pressure, hypertension, ischaemic heart disease and TIA/RIND. Furthermore, there were significant associations between WMCs and apathy, mental slowness, disinhibition, gait disturbance and focal neurologic symptoms. The multivariate logistic model revealed apathy, mental slowness and age as the most consistent predicting factors for WMCs, together with MRI as a radiological method for the detection of WMCs. CONCLUSIONS: The findings indicate that WMCs in patients with dementia are associated with a dysexecutive-related behavioural symptom profile, vascular factors related to small and large vessel diseases and age. Copyright (c) 2009 John Wiley & Sons, Ltd.
  • Jonsson, Michael, 1955, et al. (författare)
  • Low Cerebrospinal Fluid Sulfatide Predicts Progression of White Matter Lesions - The LADIS Study
  • 2012
  • Ingår i: Dementia and Geriatric Cognitive Disorders. - 1420-8008. ; 34:1, s. 61-67
  • Tidskriftsartikel (refereegranskat)abstract
    • Background/Aims: Demyelination and axonal degeneration are the hallmarks of established white matter lesions (WML). The neurochemistry of ongoing WML is only partially known. We explored cerebrospinal fluid (CSF) substances as markers of brain tissue damage in relation to progression of WML rated on magnetic resonance imaging. Methods: CSF from elderly individuals with WML was analyzed for amyloid markers, total tau, hyperphosphorylated t, neurofilament protein light subunit, sulfatide and CSF/serum-albumin ratio. After 3 years, a follow-up magnetic resonance imaging was performed. Progression of WML was rated using the Rotterdam Progression Scale (RPS). Results: 37 subjects (age 73.6 +/- 4.6 years) were included. Subjects with more pronounced progression (RPS > 2; n = 15) had lower mean sulfatide concentration at baseline as compared to subjects with no or minimal progression (RPS 0-2; n = 22) according to univariate analyses (p = 0.009). Sulfatide was the only biomarker that predicted the RPS score according to regression analysis, explaining 18.9% of the total variance (r = 0.38, p = 0.015). Conclusion: The correlation of CSF sulfatide levels and RPS scores may reflect a remyelination response to the demyelination process associated with WML. Furthermore, the results strengthen the notion that WML pathology is different from that of Alzheimer's disease.
  • Kruczyk, Marcin, et al. (författare)
  • Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment.
  • 2012
  • Ingår i: Journal of neural transmission (Vienna, Austria : 1996). - : Springer. - 1435-1463 .- 0300-9564. ; 119:7, s. 821-31
  • Tidskriftsartikel (refereegranskat)abstract
    • The objective of the present study was to evaluate a Monte Carlo feature selection (MCFS) and rough set Rosetta pipeline for generating rule-based models as a tool for comprehensive risk estimates for future Alzheimer's disease (AD) in individual patients with mild cognitive impairment (MCI). Risk estimates were generated on the basis of age, gender, Mini-Mental State Examination scores, apolipoprotein E (APOE) genotype and the cerebrospinal fluid (CSF) biomarkers total tau (T-tau), phospho-tau(181) (P-tau) and the 42 amino acid form of amyloid β (Aβ42) in two sets of longitudinally followed MCI patients (n = 217 in total). The predictive model was created in Rosetta, evaluated with the standard tenfold cross-validation approach and tested on an external set. Features were ranked and selected by the MCFS algorithm. Using the combined pipeline of MCFS and Rosetta, it was possible to predict AD among patients with MCI with an area under the receiver operating characteristics curve of 0.92. Risk estimates were produced for the individual patients and showed good correlation with actual diagnosis in cross validation, and on an external dataset from a new study. Analysis of the importance of attributes showed that the biochemical CSF markers contributed the most to the predictions, and that added value was gained by combining several biochemical markers. Despite a correlation with the biochemical markers, the genetic marker APOE ε4 did not contribute to the predictive power of the model.
  • Mattsson, Niklas, 1979, et al. (författare)
  • Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
  • 2012
  • Ingår i: Journal of Alzheimer's disease : JAD. - 1875-8908 .- 1387-2877. ; 30:4, s. 767-78
  • Tidskriftsartikel (refereegranskat)abstract
    • Cerebrospinal fluid (CSF) measurements of amyloid-β42 (Aβ42), total-tau (T-tau), and phosphorylated tau (P-tau) may be used to predict future Alzheimer's disease (AD) dementia in patients with mild cognitive impairment (MCI). The precise temporal development of these biomarkers in relation to clinical progression is unclear. Earlier studies have been hampered by short follow-up. In an MCI cohort, we selected 15 patients who developed AD (MCI-AD) and 15 who remained cognitively stable during 4 years of follow-up. CSF was sampled at three serial occasions from each patient and analyzed for Aβ peptides, the soluble amyloid-β protein precursor protein fragments sAβPPα and sAβPPβ, T-tau, P-tau, and chromogranin B, which is a protein linked to regulated neuronal secretion. We also measured, for the first time in MCI patients, an extended panel of Aβ peptides by matrix-assisted-laser-desorption/ionization time-of-flight mass spectrometry (MS). Most biomarkers were surprisingly stable over the four years with coefficients of variation below or close to 10%. However, MCI-AD patients decreased in CSF AβX₋₄₀ and chromogranin B concentrations, which may indicate a reduced number of functional neurons or synapses with disease progression. The MS Aβ peptide panel was more useful than any single Aβ peptide to identify MCI-AD patients already at baseline. Knowledge on these biomarkers and their trajectories may facilitate early diagnosis of AD and be useful in future clinical trials to track effects of disease modifying drugs.
  • Nordlund, Arto, 1962, et al. (författare)
  • Cognitive profiles of incipient dementia in the Goteborg MCI study.
  • 2010
  • Ingår i: Dementia and geriatric cognitive disorders. - 1421-9824. ; 30:5, s. 403-10
  • Tidskriftsartikel (refereegranskat)abstract
    • To study which cognitive profiles of incipient dementia strongest predict the conversion to Alzheimer's disease (AD) and mixed dementia (MD)/vascular dementia (VaD).
  • Nordlund, Arto, 1962, et al. (författare)
  • Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI
  • 2008
  • Ingår i: Journal of the International Neuropsychological Society. - 1355-6177. ; 14:4, s. 582-590
  • Tidskriftsartikel (refereegranskat)abstract
    • Mild cognitive impairment (MCI) is regarded as the prodromal stage of dementia disorders, such as Alzheimer's disease (AD). Objective: To compare the neuropsychological profiles of MCI subjects with normal concentrations of total tau (T-τ) and Aβ42 in CSF (MCI-norm) to MCI subjects with deviating concentrations of the biomarkers (MCI-dev). MCI-norm (N = 73) and MCI-dev (N = 73) subjects were compared to normal controls (N = 50) on tests of speed/attention, memory, visuospatial function, language and executive function. Results: MCI-norm performed overall better than MCI-dev, specifically on tests of speed and attention and episodic memory. When MCI-dev subjects were subclassified into those with only high T-tau (MCI-tau), only low Aβ42 (MCI-Aβ) and both high T-tau and low Aβ42 (MCI-tauAβ), MCI-tauAβ tended to perform slightly worse. MCI-tau and MCI-Aβ performed quite similarly. Conclusions: Considering the neuropsychological differences, many MCI-norm probably had more benign forms of MCI, or early non-AD forms of neurodegenerative disorders. Although most MCI-dev performed clearly worse than MCI-norm on the neuropsychological battery, some did not show any deficits when compared to age norms. A combination of CSF analyses and neuropsychology could be a step toward a more exact diagnosis of MCI as prodromal AD.
Skapa referenser, mejla, bekava och länka
  • Resultat 21-30 av 46
  • Föregående 12[3]45Nästa
Typ av publikation
tidskriftsartikel (43)
konferensbidrag (1)
doktorsavhandling (1)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (44)
övrigt vetenskapligt (2)
Rolstad, Sindre, 197 ... (46)
Wallin, Anders, 1950 (37)
Nordlund, Arto, 1962 (18)
Eckerström, Carl (18)
Zetterberg, Henrik, ... (17)
Blennow, Kaj, 1958 (16)
visa fler...
Edman, Åke (13)
Göthlin, Mattias, 19 ... (11)
Jonsson, Michael, 19 ... (10)
Rolstad, S (9)
Eckerström, Marie, 1 ... (9)
Bjerke, Maria, 1977 (8)
Lind, Karin, 1952 (8)
Landén, Mikael, 1966 (7)
Landen, M (7)
Olsson, Erik, 1960 (7)
Hansen, Stefan, 1953 (6)
Johansson, Boo (6)
Ekman, CJ (5)
Svensson, Johan, 196 ... (5)
Berg, Anne Ingeborg, ... (5)
Palsson, E (5)
Pålsson, Erik, 1975 (5)
Gustavsson, Marie, 1 ... (5)
Abé, C (4)
Sellgren, C (4)
Malmgren, Helge, 194 ... (4)
Klang, Ola (4)
Blennow, K (3)
Ekman, Carl-Johan (3)
Kettunen, Petronella (3)
Andreasson, Ulf, 196 ... (3)
Zetterberg, H. (2)
Ekman, C-J (2)
Sellgren, Carl (2)
Olsson, E (2)
Joas, Erik, 1983 (2)
Jakobsson, J. (2)
Mattsson, Niklas, 19 ... (2)
Sacuiu, Simona, 1971 (2)
Sjögren, Magnus (2)
Jakobsson, Joel (2)
Klasson, Niklas (2)
Joas, E (2)
Öhrfelt Olsson, Anni ... (2)
Stålhammar, Jacob, 1 ... (2)
Pedersen, Mona (2)
Merrill, Charley A. (2)
Sjögren, Magnus J. C ... (2)
Carlsson, Mårten (2)
visa färre...
Göteborgs universitet (46)
Karolinska Institutet (8)
Uppsala universitet (2)
Linnéuniversitetet (1)
Engelska (46)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (40)
Naturvetenskap (1)
Humaniora (1)


Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy